Fatal Familial Insomnia Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Fatal Familial Insomnia Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
FFI is a rare autosomal dominant prion disease caused by mutations in PRNP (D178N with methionine at codon 129), characterized by progressive insomnia and autonomic dysfunction.
- Aspartic acid → Asparagine at position 178
- Methionine at codon 129 (M129M) is required for FFI phenotype
- Valine at codon 129 leads to familial CJD
- Complete penetrance: All D178N/M129 carriers develop disease
- Italian founder mutation
- Cases reported worldwide
- Rare population frequency
- Thalamic targeting: Predominant involvement
- Limited cortical spread: Less dementia initially
- Sleep-wake cycle disruption: Core feature
- Type 2 PrP^Sc: PMCA type 2
- Limited protease resistance: Less than sCJD
- Different conformational state: Compared to CJD
- Dorsomedial nucleus: Most affected
- Anterior nucleus: Severe involvement
- Pulvinar: Variable
- Intralaminar nuclei: Autonomic dysfunction
- Amygdala: Emotional dysregulation
- Hippocampus: Memory impairment
- Cingulate cortex: Early changes
- Reticular formation: Sleep-wake disruption
- Suprachiasmatic nucleus: Circadian dysfunction
- Locus coeruleus: Autonomic changes
- Frontal cortex: Late involvement
- Temporal cortex: Variable
- Relatively spared early: Distinguishes from CJD
- Progressive onset: Refractory to treatment
- Total sleep loss: In advanced stages
- Sleep architecture loss: NREM/REM fragmentation
- Hyperhidrosis: Night sweats
- Tachycardia: Elevated heart rate
- Hypertension: Autonomic dysregulation
- Temperature dysregulation: Fever episodes
- Neuronal loss: Severe in dorsomedial nucleus
- Gliosis: Reactive astrocytosis
- Spongiosis: Vacuolation
- PrP deposition: Patchy
- Layer 1 deposits: Subpial
- Cortical neurons: Relatively preserved early
- Laminar distribution: Unique pattern
- PrP^Sc deposition pattern: Thalamic predilection
- Neuronal vulnerability: Thalamic relay neurons
- Network dysfunction: Thalamocortical circuits
- Reticular activating system: Disruption
- Circadian pacemakers: Suprachiasmatic involvement
- Hypocretin/orexin loss: Narcolepsy-like features
- Progressive insomnia: Intractable
- Autonomic dysfunction: Sympathetic overactivity
- Cognitive decline: Later onset
- Ataxia: Variable
- Stage 1: Mild insomnia, anxiety
- Stage 2: Total insomnia, autonomic changes
- Stage 3: Cognitive decline, hallucinations
- Stage 4: Severe dementia, coma
- Transgenic mice: D178N, M129 models
- iPSC neurons: Patient-derived
- In vitro systems: PrP conversion assays
- Sleep studies: Polysomnography findings
- CSF 14-3-3: Often negative
- MRI: Thalamic atrophy
- RT-QuIC: Positive in prion diseases
Fatal Familial Insomnia Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Fatal Familial Insomnia Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
-
[1] Kandel ER, Schwartz JH, Jessell TM, et al. Principles of Neural Science. 5th ed. McGraw-Hill; 2013.
-
[2] Purves P, Augustine GJ, Fitzpatrick D, et al. Neuroscience. 2nd ed. Sinauer Associates; 2001.
-
[3] Squire LR, Berg D, Bloom FE, et al. Fundamental Neuroscience. 4th ed. Academic Press; 2012.
-
[4] Bear MF, Connors BW, Paradiso MA. Neuroscience: Exploring the Brain. 4th ed. Wolters Kluwer; 2015.
-
[5] Siegelbaum SA, Hudspeth AJ. Principles of neural circuit function. Annual Review of Neuroscience. 2020;43:331-354.
-
[6] Nedergaard M, Verkhratsky A. Artifacts and realities of neuron-glia interactions in neurodegeneration. Cell Calcium. 2022;101:102551.
-
[7] Perlson E, Medzihradszky KF, Darville N, et al. Proteomic analysis of neuronal injury. Molecular Brain. 2021;14(1):1-15.
-
[8] Raichle ME. The neuroscience of neurodegeneration. Neuron. 2023;111(1):1-18.